Editpep has developed a class of peptides capable of conveying CRISPR enzymes into clinically-relevant and previously untransfectable cell types.
Ross Wilson
BEGIN Berkeley Gateway to Innovation portal to the UC Berkeley entrepreneurship community
Accessibility | Nondiscrimination | Privacy